Edwards/PLC Medical Deal Shows Confidence in Laser Angina Therapy
This article was originally published in The Gray Sheet
Executive Summary
Edwards LifeSciences' agreement to become the exclusive distributor of PLC Medical Systems' next-generation transmyocardial revascularization system, announced Jan. 9, demonstrates the Baxter spin-off's belief in the validity of a technology that has yet to be fully embraced by the market.